Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
Rhea-AI Summary
Aveanna (NASDAQ: AVAH) will release fourth quarter and full year 2025 results before market open on Thursday, March 19, 2026, followed by a conference call at 10:00 a.m. ET.
Investors can join by phone or webcast; a replay with passcode 13757396 will be available three hours after the call through March 26, 2026, and an online replay will remain for one week.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Pre-news, AVAH gained 2.12% while key peers were mixed: NHC up 1.8%, ARDT up 0.92%, SEM roughly flat at 0.07%, BKD down 2.39%, and PIII unchanged. Momentum scanner only flagged PACS (up 1.37%) with no related news, supporting a stock-specific move rather than a broad sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 11 | Program certification | Positive | +1.5% | Heartways program earned CHAP Disease Program Certification for heart failure care. |
| Jan 14 | Guidance update | Neutral | +10.0% | Company issued updated full year 2025 and initial 2026 guidance outlook. |
| Dec 17 | Investor conference | Positive | +1.6% | Announced participation and presentation at J.P. Morgan Healthcare Conference. |
| Dec 04 | Investor conference | Positive | +1.9% | Planned presentation and meetings at BofA Securities Home Care Conference. |
| Nov 06 | Earnings and outlook | Positive | -6.3% | Reported strong Q3 2025 growth and raised 2025 guidance alongside liquidity details. |
Recent news has often seen modest positive reactions, but the strong Q3 2025 fundamental beat and guidance raise drew a negative price response, indicating occasional divergences on major financial updates.
Over the last few months, Aveanna highlighted several developments: CHAP Disease Program Certification for its Heartways heart failure program on Feb 11, 2026, updated full‑year 2025 and initial 2026 guidance on Jan 14, 2026, and investor-facing conference appearances in December 2025. On Nov 6, 2025, Q3 2025 results showed strong revenue and EBITDA growth with raised 2025 guidance, yet the stock fell 6.3%. Today’s announcement only sets the March 19, 2026 earnings release and call, continuing a pattern of regular investor communication.
Market Pulse Summary
This announcement sets Aveanna’s timetable for releasing its Q4 and full year 2025 results on March 19, 2026, with a conference call at 10:00 a.m. ET. It follows recent milestones, including CHAP certification for the Heartways program and strong Q3 2025 results with raised 2025 guidance. Investors may focus on how the upcoming report updates revenue, profitability, guidance, and liquidity trends highlighted in prior quarters.
AI-generated analysis. Not financial advice.
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 19, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13757396. The replay will be available until March 26, 2026.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for one week following the call.
About Aveanna Healthcare
Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.
Investor Contact Matt Buckhalter Chief Financial Officer Ir@aveanna.com
FAQ
When will Aveanna (AVAH) release Q4 and full year 2025 earnings and hold the conference call?
How can investors access the Aveanna (AVAH) March 19, 2026 earnings call live?
What are the replay options and timing for the Aveanna (AVAH) March 19, 2026 conference call?
What passcode is required to access the Aveanna (AVAH) live call and replay on March 19, 2026?
Where will the Aveanna (AVAH) webcast for the March 19, 2026 earnings call be hosted?
What international dial-in options are available for the Aveanna (AVAH) March 19, 2026 earnings call?
